Concert Pharmaceuticals Top Management

CNCEDelisted Stock  USD 8.37  0.01  0.12%   
Concert Pharmaceuticals employs about 64 people. The company is managed by 9 executives with a total tenure of roughly 65 years, averaging almost 7.0 years of service per executive, having 7.11 employees per reported executive. Evaluation of Concert Pharmaceuticals' management performance can provide insight into the firm performance.
Roger Tung  CEO
Co-Founder, CEO and President and Director
James Cassella  President
Senior Vice President chief development officer
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Concert Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.3853) % which means that it has lost $0.3853 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0868) %, meaning that it created substantial loss on money invested by shareholders. Concert Pharmaceuticals' management efficiency ratios could be used to measure how well Concert Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Concert Pharmaceuticals Workforce Comparison

Concert Pharmaceuticals is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 26,807. Concert Pharmaceuticals adds roughly 64.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Concert Pharmaceuticals Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Concert Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Concert Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Concert Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Concert Pharmaceuticals Notable Stakeholders

A Concert Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Concert Pharmaceuticals often face trade-offs trying to please all of them. Concert Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Concert Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Roger TungCo-Founder, CEO and President and DirectorProfile
James CassellaSenior Vice President chief development officerProfile
Christine BoisclairVice President - Regulatory AffairsProfile
Justine KoenigsbergVP of Corporate Communications and Investor RelationsProfile
Nancy StuartChief OfficerProfile
Marc BeckerChief OfficerProfile
Jeffrey MunsieChief SecProfile
Nabil PharmDVP DevelProfile
Mba MBACoFounder ChairmanProfile

About Concert Pharmaceuticals Management Performance

The success or failure of an entity such as Concert Pharmaceuticals often depends on how effective the management is. Concert Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Concert management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Concert management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. Concert Pharmaceutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 64 people.
Please note, the presentation of Concert Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Concert Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Concert Pharmaceuticals' management manipulating its earnings.

Concert Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Concert Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Concert Pharmaceuticals within its industry.

Concert Pharmaceuticals Manpower Efficiency

Return on Concert Pharmaceuticals Manpower

Revenue Per Employee509
Revenue Per Executive3.6K
Net Loss Per Employee1.3K
Net Loss Per Executive8.9K
Working Capital Per Employee2.1M
Working Capital Per Executive15.3M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Consideration for investing in Concert Stock

If you are still planning to invest in Concert Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Concert Pharmaceuticals' history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum